Bruker Corp. Aktie
Bruker Corp. Aktie
Was spricht für und gegen Bruker Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Bruker Corp. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | -4,08 % | 0,09 % | -6,27 % | -24,16 % | -17,11 % | - | - |
| Healthequity Inc. | -0,76 % | 2,34 % | -4,38 % | -33,50 % | -16,03 % | 5,65 % | -2,24 % |
| Omnicell Inc. | -1,14 % | 2,37 % | -10,36 % | -2,81 % | -10,82 % | -34,72 % | -67,05 % |
| Myriad Genetics | -1,88 % | 11,76 % | -7,11 % | -57,56 % | -21,13 % | -80,85 % | -82,29 % |
Kommentare
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a




